Patent ID: 8083726
Filing Date: 2011-12-27
Classification: A61B,A61L,A61M

Abstract:
1. A method comprising: providing a cellular component having a property that can provide an angiogenic response; providing a biodegradable viability enhancer material comprising a cross-linked hydrogel; combining the cellular component and the viability enhancer material such that the viability enhancer material encapsulates the cellular component such that the combination will inhibit an interaction between the cellular component and a delivery device; introducing the combination in a gel form suitable for delivery through the delivery device into a proximal portion of the delivery device; and transluminally delivering the combination in the gel form to one or more of a vessel and a tissue through a needle at a distal portion of the delivery device, wherein the delivery device is positioned within the vessel and the needle is advanced through a wall of the vessel to direct a flow of the liquid into the vessel or tissue.